News | ASTRO | December 20, 2022

ASTRO's statement stresses that it is deeply disappointed in radiation oncology cuts and fears for stability of community-based cancer clinics

ASTRO's statement stresses that it is deeply disappointed in radiation oncology cuts and fears for stability of community-based cancer clinics

Getty Images


December 20, 2022 — The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board of Directors Chair Geraldine Jacobson, MD, MBA, MPH, FASTRO, in response to today’s release of the Fiscal Year 2023 Omnibus Appropriations bill.
"On behalf of ASTRO’s 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating cancer patients with radiation therapy, ASTRO is disappointed that Congress failed to stop the full Medicare physician payment cuts for 2023, demonstrating that the Medicare physician payment system is broken. Radiation oncology has faced among the most significant cuts of any medical specialty, leaving community-based clinics at the breaking point. We urge the new Congress to immediately begin payment reform discussions, including working with ASTRO and the radiation oncology community to create a new, sustainable payment approach for radiation therapy services.

The omnibus package leaves all physicians with a 2% reduction in the Medicare physician payment conversion factor for 2023, and radiation oncology with an additional 1% decrease due to clinical labor price changes, at a time when patients are returning to clinics and facing more complex cancer care due to delays caused by the pandemic. Cancer clinics must also contend with a wide range of increasing overhead and staffing costs when determining their ability to provide care to Medicare beneficiaries. Payment relief in the omnibus bill is insufficient and could endanger some clinics’ ability to stay open and provide needed care to people with cancer.”

For more information: www.astro.org


Related Content

News | Radiopharmaceuticals and Tracers

September 27, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 27, 2023
arrow
News | Radiation Therapy

September 27, 2023 — The American Society for Radiation Oncology (ASTRO) announced the three winning research proposals ...

Time September 27, 2023
arrow
News | Breast Imaging

September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two ...

Time September 27, 2023
arrow
News | Mammography

September 26, 2023 — Artificial intelligence(AI) and machine learning tools have received a lot of attention recently ...

Time September 26, 2023
arrow
Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
arrow
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Artificial Intelligence

September 20, 2023 — Medical imaging artificial intelligence (AI) company Annalise.ai has announced that the results ...

Time September 20, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
Subscribe Now